3 Green Flags for AstraZeneca's Future
AstraZeneca's (NYSE: AZN) coronavirus vaccine program is one of six that have reached phase 3 clinical trials, the last step before regulatory approval. So we can fairly say the big pharmaceutical company is a leader in the race to develop a vaccine for COVID-19. Moderna (NASDAQ: MRNA) is another leader, as are Pfizer (NYSE: PFE) and biotech company BioNTech (NASDAQ: BNTX), which are collaborating in their efforts. Two Chinese companies complete the list of top players.
Considering the competition, one might ask whether AstraZeneca has a chance of winning this race. It's impossible to predict which company will bring a vaccine to market first. But we do have some clues about each company's possibilities moving forward.
Image source: Getty Images.
Source Fool.com
